India's Biocon urges government to exempt cancer, rare-disease drugs from tax in budget
India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...
Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?
The market may extend its upward journey, but sustainability is the key to watch, given the elevated volatility. Below are ...
Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade
According to reports, HSBC said that Biocon is well-placed for an operational turnaround, driven by key biosimilar launches ...
biopharma-reporter4h
Biosimilars in the UK: Insights from Biocon Biologics
Josh Gissing is Cluster Head (UK, Ireland & Nordics) for Biocon Biologics: a biosimilars company whose business model seeks ...
Trade Spotlight: How should you trade Biocon, Maruti Suzuki, Navin Fluorine, Gujarat Apollo, Bharat Dynamics, and others on January 20?
The market is expected to sustain range-bound trading, and the elevated volatility signals caution for bulls. Below are some ...
Daily1d
Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt
Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and ...
cnbctv187d
Biocon shares surge 5% after another upgrade; HSBC expects stock to hit ₹430
HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...
ndtvprofit7d
Biocon Share Price Jumps After HSBC’s 'Buy' Upgrade
With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...
ndtvprofit8d
Biocon Shares Rise Over 4% After USFDA Clearance For Malaysia Insulin Units
After the clearance from US drugs regulator, Motilal Oswal has upgraded Biocon to 'buy' with a target price of Rs 430 apiece.
CCI slaps ₹40 lakh fine on Goldman Sachs for failure to notify investment in Biocon Biologics
CCI fines Goldman Sachs for undisclosed investment in Biocon, highlighting need for compliance with competition laws in ...
Stock Radar: Biocon stock price breaks out from upper band of a Symmetrical Triangle; should you buy?
Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.
Business Today4d
Biocon Ltd (BIOCON) Share Price
Biocon Ltd share price was up by 0.14% from the previous closing price of ₹393.15. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...